The story of Viagra and its originator, copyright, presents a complex picture for prospective investors. While the blockbuster drug initially generated enormous profits , its patent has lapsed , leading to generic alternatives flooding the landscape . This decline in value presents a real challenge for copyright and any portfolio considering a l… Read More